Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Targeting FOXM1 in cancer.
Halasi M, Gartel AL. Halasi M, et al. Among authors: gartel al. Biochem Pharmacol. 2013 Mar 1;85(5):644-652. doi: 10.1016/j.bcp.2012.10.013. Epub 2012 Oct 24. Biochem Pharmacol. 2013. PMID: 23103567 Review.
Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes.
Gartel AL, Shchors K. Gartel AL, et al. Exp Cell Res. 2003 Feb 1;283(1):17-21. doi: 10.1016/s0014-4827(02)00020-4. Exp Cell Res. 2003. PMID: 12565816 Review.
A new method for determining the status of p53 in tumor cell lines of different origin.
Gartel AL, Feliciano C, Tyner AL. Gartel AL, et al. Oncol Res. 2003;13(6-10):405-8. doi: 10.3727/096504003108748429. Oncol Res. 2003. PMID: 12725531
RNA interference as a new strategy against viral hepatitis.
Radhakrishnan SK, Layden TJ, Gartel AL. Radhakrishnan SK, et al. Among authors: gartel al. Virology. 2004 Jun 1;323(2):173-81. doi: 10.1016/j.virol.2004.02.021. Virology. 2004. PMID: 15193913 Review.
The PPAR-gamma agonist pioglitazone post-transcriptionally induces p21 in PC3 prostate cancer but not in other cell lines.
Radhakrishnan SK, Gartel AL. Radhakrishnan SK, et al. Among authors: gartel al. Cell Cycle. 2005 Apr;4(4):582-4. Epub 2005 Apr 2. Cell Cycle. 2005. PMID: 15738655
Lost in transcription: p21 repression, mechanisms, and consequences.
Gartel AL, Radhakrishnan SK. Gartel AL, et al. Cancer Res. 2005 May 15;65(10):3980-5. doi: 10.1158/0008-5472.CAN-04-3995. Cancer Res. 2005. PMID: 15899785 Review.
RNA interference in cancer.
Gartel AL, Kandel ES. Gartel AL, et al. Biomol Eng. 2006 Mar;23(1):17-34. doi: 10.1016/j.bioeng.2006.01.002. Epub 2006 Feb 8. Biomol Eng. 2006. PMID: 16466964 Review.
A novel transcriptional inhibitor induces apoptosis in tumor cells and exhibits antiangiogenic activity.
Radhakrishnan SK, Gartel AL. Radhakrishnan SK, et al. Among authors: gartel al. Cancer Res. 2006 Mar 15;66(6):3264-70. doi: 10.1158/0008-5472.CAN-05-3940. Cancer Res. 2006. PMID: 16540679
Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1.
Radhakrishnan SK, Bhat UG, Hughes DE, Wang IC, Costa RH, Gartel AL. Radhakrishnan SK, et al. Among authors: gartel al. Cancer Res. 2006 Oct 1;66(19):9731-5. doi: 10.1158/0008-5472.CAN-06-1576. Cancer Res. 2006. PMID: 17018632
P-TEFb inhibitors interfere with activation of p53 by DNA-damaging agents.
Radhakrishnan SK, Bhat UG, Halasi M, Gartel AL. Radhakrishnan SK, et al. Among authors: gartel al. Oncogene. 2008 Feb 21;27(9):1306-9. doi: 10.1038/sj.onc.1210737. Epub 2007 Sep 3. Oncogene. 2008. PMID: 17724473
92 results
Jump to page
Feedback